- | Country : -
- | organs : -
- | Specialty : -
Extract
•To demonstrate that the efficacy in achieving and maintaining testosterone castration levels (<=0.5 ng/mL) in prostate cancer patients treated up to either 12 or 13 months is at least 80%.
Inclusion criteria
- Prostate cancer